About Us
The Peer’s lab works at the interface of materials science, chemistry, molecular biology, and immunology, aiming to discover and validate novel therapeutic targets at the molecular level, and to develop targeted genetic medicines for therapeutic applications and disease management. The lab is highly dynamic, multidisciplinary, focusing on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi , mRNA, saRNA, cirRNA, DNA, and novel genome editing strategies.
The lab goal is to translate academic discoveries into innovative therapeutic modalities. With that in mind, Prof. Peer also founded SPARK Tel Aviv to accelerate cures via academic discoveries. Prof. Peer strives to develop the career of young students and encourage them to fulfill their ambitions and dreams.
Prof. Dan Peer
.png)
Dan Peer is the director of the Laboratory of Precision NanoMedicine at Tel Aviv University. He is also the Vice President for Research and Development at Tel Aviv University. His lab works in the interface of basic and translational science. In addition, Prof. Peer is the Founder and Managing Director of the SPARK Tel Aviv, Center for Translational Medicine.
Moreover, Prof. Peer is on the Scientific Advisory Board of numerous international companies and an invited keynote speaker at many conferences. In 2014 he was elected to the Israel Young Academy.In 2023 he was elected to the US National Academy of Engineering.In 2024 he was elected as a Fellow of the US National Academy of Inventors.Laboratory of Precision NanoMedicin.
email: peer@tauex.tau.ac.il
Learn More about our work
Prof. Dan Peer, Tel Aviv University:
Therapeutic genome editing in cancer
Prof Dan peer, Tel Aviv University:
v13 Lipid Nanoparticles
Prof. Dan Peer, Tel Aviv University:
A technology for cell-specific delivery of nucleic acids
Prof Dan peer, Tel Aviv University:
Therapeutic RNAs Delivery to Leukocytes